Human Multidrug resistance-1 gene expression levels in Graves-Basedow disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 3, 2010, Pages 158-160

  Cetinkalp S ^a   Karadeniz, M ^a   Erdogan M ^a   Eroglu Z ^a   Zengi, A ^a   Kosova, B ^a   Yilmaz, C ^a   Tezcanli, B ^a   Kabalak, T ^a   Ozgen A G ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Graves Basedow Disease; Human Multidrug Resistance 1 Gene; Thyroid disease

Indexed keywords

LIOTHYRONINE; MULTIDRUG RESISTANCE PROTEIN 1; PROPYLTHIOURACIL; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REMISSION; THYROID GLAND; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGE FACTORS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION; GRAVES DISEASE; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PROPYLTHIOURACIL; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 77949499288     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1215586     Document Type: Article

References (28)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989 58 137-171
2. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by multidrug transporter. Annu Rev Biochem 1993 62 385-427
3. Higgins CF. ABC transporters: from microorganisms to mas. Annu Rev Cell Biol 1992 8 67-113
4. Higgins CF. The ABC of channel regulation. Cell 1995 82 693-696
5. Cordon-Cardo C, O'Brien JP, Casals D, etal. Multidrug resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci USA 1989 86 695-698
6. Thiebaut F, Tsuruo T, Hamada H, etal. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987 84 7735-7738
7. Cordon Cardo C, OBrien JP, Boccia J, etal. Expression of the multidrug resistance gene product (P-glycoprotein) in normal human and tumor tissues. J Histochem Cytochem 1990 38 1277-1287
8. Fojo AT, Ueda K, Slamon DJ, etal. Expression of a multidrug resistance gene in human and tumor tissues. Proc Natl Acad Sci USA 1987 84 265-269
9. Jorgensen C, Sun R, Rossi JF, etal. Expression of a multidrug resistance gene in human rheumatoid synovium. Reumatol Int 1995 15 83-86
10. Maillefert JF, Maynadie M, Tebib JG, etal. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol 1996 35 430-435
11. Yvonne R-P, Elena S-V, Juan J-O, etal. P-glycoprotein in autoimmune diseases. Autoimmunity Reviews 2004 3 (3) 188-192
12. Ruiz-Soto R, Richaud-Patin Y, Lopez-Karpovitch X, etal. Multidrug resistance-1 (MDR-1) in autoimmune disorders III: increased P-glycoprotein activity in lymphocytes from immune thrombocytopenic purpura patients. Exp Hematol 2003 31 483-487
13. Levy AS, Cunningham-Rundles S, Mazza B, etal. High P-glycoprotein- mediated export observed in patients with a history of idiopathic thrombocytopenic purpura. Br J Haematol 2002 118 836-838
14. Diaz-Borjon A, Richaud-Patin Y, Alvarado de la Barrera C, etal. Multidrug resistance-1 (MDR-1) in rheumatic autoimmune disorders. Part II: increased P-glycoprotein activity in lymphocytes from systemic lupus erythematosus patients might affect steroid requirements for disease control. Joint Bone Spine 2000 67 40-48
15. Londei M, Bottazzo GF, Feldmann M. Human T-cell clones from autoimmune thyroid glands: Spesific recognition of autologous thyroid cells. Science 1985 228 85-89
16. Martin A, Goldsmith NK, Friedman EW, etal. Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease. Autoimmunity 1990 6 269-281
17. Martin A, Davies TF. T cells and human autoimmune thyroid disease: Emerging data show lack of need to invoke suppressor T-cell problems. Thyroid 1992 2 247-261
18. Peter NG, Terry FD. New insights into the Thyroid-Stimulating Hormone Receptor: The major antigen of Graves Disease. Endocrinol Metab Clin North A 2000 29 (2) 267-286
19. Orgiazzi J. Anti-TSH receptor antibodies in clinical practise. Endocrinol Metab Clin North A 2000 29 (2) 339-355
20. Cooper DS. Antithyroid drugs fort he treatment of hyperthyroidism caused by Graves disease. Endocrinol Metab Clin North Am 1998 27 225-247
21. Hedley AJ, Young RE, Jones SJ. Antithyroid drugs in the treatment of hyperthyroidism of Graves disease: Long term follow-up of 434 patient. Scottish Automated Follow-up Register Group. Clin Endocrinol (Oxf) 1989 31 209-218
22. Alsanea O, Clark O. Treatment of Graves disease: The advantages of surgery. Endocrinol Metab Clin North A 2000 29 (2) 321-337
23. Ford JM. Modulators of multidrug resistance. Preclinical studies. Hematol/Oncol Clin North A 1995 9 337-359
24. Truman JP, Garban F, Choqueux C, etal. HLA class II signaling mediates cellular activation and programmed cell death. Exp Hematol 1996 24 1409-1415
25. Distelhorst CW, Dubyak G. Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theries by new finding. Blood 1998 91 731-734
26. Vilpo J, Koski T, Vilpo L. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro. Haematologica 2000 85 806-813
27. OBrian CA, Ward NE, Stewart JR, etal. Prospects for targeting protein kinase C isozyme in the therapy of drug resistant cancer-an evolving story. Cancer Metastasis Rev 2001 20 95-100
28. Yudoh K, Matsuno H, Nakazawa F, etal. Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis. Arthritis Rheum 1999 42 2014-2015